Eli Lilly, Teladoc Health and LifeMD
Eli Lilly expands telehealth access to low-cost Zepbound with Teladoc Health, LifeMD tie-ups
Eli Lilly partnered up with telehealth providers LifeMD and Teladoc Health to offer its lower cost, single-vial Zepbound (tirzepatide) to patients in the virtual c | The move could be a boon for telehealth weight loss programs,
Proficio Capital Partners LLC acquired a new stake in shares of Teladoc Health, Inc. (NYSE:TDOC – Free Report) in the fourth ...
Blue Orca Capital, an Austin, Texas-based short-seller firm, tried to drive the price of Teladoc Health down in February by ...
Teladoc Health released its full-year 2024 earnings Wednesday. Executives touted the growth of the chronic care management ...
Zacks Investment Research on MSN4d
Teladoc Health Enhances Prism Platform for Better Virtual CareTeladoc Health, Inc. TDOC recently introduced new enhancements to its proprietary care delivery platform, Prism. The platform ...
Eligible Teladoc Health members, if prescribed Zepbound ® by their Teladoc Health provider for an on-label indication, can have single-use Zepbound ® vials delivered directly to their home. Teladoc ...
Teladoc posted a net loss of just over $1 billion in 2024 related to ongoing struggles at its direct-to-consumer BetterHelp ...
Teladoc Health (NYSE:TDOC) recently announced a pharmacy integration agreement with Eli Lilly, which aims to enhance access to GLP-1 medications for obesity as part of their Comprehensive Weight Care ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback